European Medicines Agency looks at colistin use in animals following mcr-1 gene discovery

The European Medicines Agency (EMA) has received a request from the European Commission to update its advice on the use in animals of colistin, which is one of the last-resort antibiotics to treat certain bacterial infections in humans. This follows the recent discovery of a gene (called mcr-1) that causes bacteria to become resistant to ["]